Browse All

Current Filters

CLEAR FILTER x

TITLE

Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies

Author:Seth, Nilufer   Xu, Rui   Tyler, Steven   Avery, William   Beavers, Traymon   Prage, Viraj   Sihapong, Sam   Brown, Julia   Bhattacharya, Sayak   Ramchandren, Sindhu   Heerlein, Kristin   Sun, Hong   Abouzahr, Katie   Ling, Leona   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.008  

Author Institution:J&J, Spring House, PA  J&J, San Diego, CA  AVROBIO Inc, Boston, MA  Kisbee Therapeutics, Cambridge, MA  J&J, Cambridge, MA  J&J, La Jolla, CA  J&J, Knoxville, TN  J&J, Neuss, Germany  J&J, Princeton, NJ  

Uncontrolled Myasthenia Gravis Can Contribute to Additional Stress Burden and Adverse Mental Health Experiences

Author:Gwathmey, Kelly   Rodriguez, Rachelle   Choudhry, Zia   Jackson, Louis   Peters, Wesley   Geonnotti, Gabrielle   Ramchandren, Sindhu   Ait-Tihyaty, Maria   Goyal, Neelam   

Session Name:P4: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P4.019  

Author Institution:VCU Neuroscience, Orthopedic, and Wellness, Henrico, VA  The Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan, NJ  The Janssen Pharmaceutical Companies of Johnson & Johnson , Horsham, PA  The Janssen Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ  Corevitas, Waltham, MA  The Janssen Pharmaceutical Companies of Johnson & Johnson, Knoxville, TN  Stanford University, Palo Alto, CA